Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intensity-modulated radiotherapy.

Steven A Leibel1, Zvi Fuks, Michael J Zelefsky

  • 1Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

Cancer Journal (Sudbury, Mass.)
|May 15, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dosimetric Predictors of Problematic Receptive Anal Intercourse After Prostate Radiation Therapy.

Advances in radiation oncology·2026
Same author

In Reply to DeLaney.

International journal of radiation oncology, biology, physics·2026
Same author

Dosimetric Correlates of Acute Toxicities for Moderate Hypofractionated Whole-Breast Irradiation: Implications for ASTRO Planning Guidelines.

Advances in radiation oncology·2026
Same author

Neurogenic thoracic outlet syndrome secondary to an unilateral cervical rib in a poodle mix.

Journal of veterinary internal medicine·2026
Same author

Empirical oral AntibioticS for possible UTI in well appearing Young febrile infants (EASY).

NIHR open research·2026
Same author

Reirradiation Collaborative Group (ReCOG) consensus on standards for dose evaluation and reporting in patients with multiple courses of radiation therapy: an AAPM/ACRO/ASTRO/CARO/COMP/CADRA/CPQR/ESTRO/NRG-endorsed consensus statement.

The Lancet. Oncology·2026
Same journal

Present and Emerging Strategies for Disease Assessment in Hodgkin Lymphoma.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Nodular Lymphocyte-predominant Hodgkin Lymphoma: Incidence, Pathogenesis, Management.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Management of Classic Hodgkin Lymphoma in Special Clinical Situations.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Older Patients With Hodgkin Lymphoma: A Contemporary Review.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Adolescent and Young Adult Patients With Classical Hodgkin Lymphoma: A Review as a Case Study in AYA Cancer Care.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Hodgkin Lymphoma: Management of Patients Who Fail Primary Therapy.

Cancer journal (Sudbury, Mass.)·2026
See all related articles

Intensity-modulated radiotherapy (IMRT) precisely targets tumors using advanced technology, improving cancer treatment. This method allows higher radiation doses while minimizing damage to surrounding healthy tissues, enhancing patient outcomes.

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Oncology

Background:

  • Intensity-modulated radiotherapy (IMRT) is an advanced form of conformal radiotherapy.
  • It utilizes specialized computer technology for precise dose distribution conforming to tumor targets.

Purpose of the Study:

  • To highlight the advancements and benefits of IMRT in cancer treatment.
  • To discuss the potential of IMRT in improving tumor targeting and dose delivery.

Main Methods:

  • IMRT employs inverse planning algorithms and iterative computer-driven optimization.
  • Treatment fields with varying intensities are generated and combined for custom dose distributions.

Main Results:

  • IMRT demonstrates improved tumor targeting precision across various cancers, including prostate, head and neck, and lung.

Related Experiment Videos

  • Reduced rectal toxicity and dose escalation capabilities were observed in prostate cancer patients.
  • Steep dose gradients effectively spare adjacent normal tissues.

    • Conclusions:

    • IMRT is a significant advancement in delivering high radiation doses for improved local tumor control.
    • Future research focuses on integrating biologically based imaging for differential dose painting and personalized treatment.